Lymphopenia confers poorer prognosis in Myelodysplastic Syndromes with very low and low IPSS-M
Open Access
- 21 December 2023
- journal article
- letter
- Published by Springer Nature in Blood Cancer Journal
- Vol. 13 (1) , 1-5
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Prognostic relevance of lymphocytopenia, monocytopenia and lymphocyte-to-monocyte ratio in primary myelodysplastic syndromes: a single center experience in 889 patientsBlood Cancer Journal, 2017
- Impaired cytotoxicity associated with defective natural killer cell differentiation in myelodysplastic syndromesHaematologica, 2015
- Full blood count normal reference values for adults in FranceJournal of Clinical Pathology, 2013
- Revised International Prognostic Scoring System for Myelodysplastic SyndromesBlood, 2012
- Host immunity affects survival in myelodysplastic syndromes: Independent prognostic value of the absolute lymphocyte countAmerican Journal of Hematology, 2009
- Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and LymphomasCancer Research, 2009
- IL‐17‐producing CD4+T cells, pro‐inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndromeBritish Journal of Haematology, 2009
- Myelodysplastic syndromes associated with interstitial deletion of chromosome 5q: Clinicopathologic correlations and new insights from the prelenalidomide eraAmerican Journal of Hematology, 2008
- Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptorsBlood, 2007
- Evidence for reduced B-cell progenitors in early (low-risk) myelodysplastic syndromeBlood, 2005